Post-treatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer. [electronic resource]
Producer: 20051213Description: 393-7 p. digitalISSN:- 0028-2685
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- blood
- Combined Modality Therapy
- Female
- Head and Neck Neoplasms -- blood
- Humans
- Male
- Middle Aged
- Neoplasms, Squamous Cell -- blood
- Predictive Value of Tests
- Prognosis
- Radiotherapy
- Transforming Growth Factor beta -- analysis
- Transforming Growth Factor beta1
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.